INCIDENCE AND PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS, HEPATITIS-B VIRUS, HEPATITIS-C VIRUS, AND CYTOMEGALOVIRUS AMONG HEALTH-CARE PERSONNEL AT RISK FOR BLOOD EXPOSURE - FINAL REPORT FROM A LONGITUDINAL-STUDY

被引:195
作者
GERBERDING, JL
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT MED INFECT DIS,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT EPIDEMIOL & BIOSTAT,SAN FRANCISCO,CA 94143
关键词
D O I
10.1093/infdis/170.6.1410
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In a 10-year dynamic cohort study, 976 health care providers were followed a mean of 1.9 years to evaluate the risk of human immunodeficiency virus (HIV) transmission, delayed seroconversion, and seronegative latent infection following occupational exposures. The seroprevalence and incidence of HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), and cytomegalovirus (CMV) infection were also measured, with annual serologic testing for viruses and postexposure HIV tests. One of 327 percutaneous exposures (0.31%; confidence interval, 0.008%-1.69%) and 0 of 398 mucocutaneous exposures to HIV-infected blood transmitted HIV. Neither delayed seroconversions nor seronegative latent infections were detected. The baseline seroprevalences of HBV, HIV, HCV, and CMV infection were 21.7%, 0, 1.4%, and 43.4%, respectively. Corresponding incidence density rates were 3.05, 0.055, 0.08, and 2.48 (per 100 person-years). Despite infection control precautions and availability of hepatitis B vaccine, these health care providers remain at risk for acquiring bloodborne viral infections.
引用
收藏
页码:1410 / 1417
页数:8
相关论文
共 60 条
[1]  
ARRANZ M, 1989, INT C BLOOD BORNE IN
[2]   CYTOMEGALOVIRUS IS NOT AN OCCUPATIONAL RISK FOR NURSES IN RENAL-TRANSPLANT AND NEONATAL UNITS - RESULTS OF A PROSPECTIVE SURVEILLANCE STUDY [J].
BALFOUR, CL ;
BALFOUR, HH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (14) :1909-1914
[3]   HIGH PREVALENCE OF HEPATITIS-C VIRUS (HCV) RNA IN DIALYSIS PATIENTS - FAILURE OF COMMERCIALLY AVAILABLE ANTIBODY TESTS TO IDENTIFY A SIGNIFICANT NUMBER OF PATIENTS WITH HCV INFECTION [J].
BUKH, J ;
WANTZIN, P ;
KROGSGAARD, K ;
KNUDSEN, F ;
PURCELL, RH ;
MILLER, RH .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) :1343-1348
[4]  
CARLSON JR, 1988, JAMA-J AM MED ASSOC, V260, P674
[5]  
CAVALCANTE N J F, 1991, AIDS Care, V3, P311, DOI 10.1080/09540129108253078
[6]   HIV-SPECIFIC T-HELPER ACTIVITY IN SERONEGATIVE HEALTH-CARE WORKERS EXPOSED TO CONTAMINATED BLOOD [J].
CLERICI, M ;
LEVIN, JM ;
KESSLER, HA ;
HARRIS, A ;
BERZOFSKY, JA ;
LANDAY, AL ;
SHEARER, GM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (01) :42-46
[7]  
DELEON SP, 1988, INFECT CONT HOSP EP, V9, P101
[8]  
DEMMLER GJ, 1987, J INFECT DIS, V56, P9
[9]   QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS DNA BY USING THE POLYMERASE CHAIN-REACTION [J].
DICKOVER, RE ;
DONOVAN, RM ;
GOLDSTEIN, E ;
DANDEKAR, S ;
BUSH, CE ;
CARLSON, JR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) :2130-2133
[10]  
DIXON WJ, 1992, BMDP STATISTICAL SOF